RxDoctor Payments Data

Madeline Knott, MD

Family Medicine · Soddy Daisy, TNNPI 1164927380

Payments from drug & device makers

$708in general payments, 2019–2025

Across 38 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$137
  • AstraZeneca$109
  • Lilly USA, LLC$107
  • Novo Nordisk$94
  • Pfizer$93
  • Astellas Pharma US Inc$63
  • plus $103 from 4 others

What the payments were for

  • Food & beverage$708100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$708 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$39,868
Medicare patients
116
Services billed
802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$81,381
EliquisApixaban45$58,419
RybelsusSemaglutide34$46,517
FarxigaDapagliflozin Propanediol42$40,632
XareltoRivaroxaban23$33,586
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$26,849
LinzessLinaclotide16$21,742
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$19,790
Repatha SureclickEvolocumab12$16,873
EntrestoSacubitril/Valsartan11$12,677
MounjaroTirzepatide12$12,337
Soliqua 100-33Insulin Glargine/Lixisenatide13$8,984
JardianceEmpagliflozin13$8,582
Combivent RespimatIpratropium/Albuterol Sulfate14$8,255
MyrbetriqMirabegron12$7,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$94$127,898119 claims
PfizerEliquis$93$58,41945 claims
AstraZenecaFarxiga$109$40,63242 claims
AbbVieLinzess, Synthroid$137$23,32340 claims
Lilly USA, LLCMounjaro$107$12,33712 claims
Astellas Pharma US IncMyrbetriq$63$7,82712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Soddy Daisy

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →